-
-
The WHI and the WELL-HART clinical trials report that hormone therapy does not reduce the risk of coronary events or slow the progression of atherosclerosis in older women.
-
Twelve cycles of single-agent paclitaxel administered to women with advanced ovarian cancer who attain a clinically defined complete response to initial platinum/paclitaxel-based chemotherapy significantly prolongs the duration of progression-free survival.
-
Umbilical artery Doppler as a screening test for fetal well-being in a high-risk population was associated with a decreased incidence of cesarean delivery for fetal distress compared to the nonstress testing, with no increase in neonatal morbidity.
-
In women with threatened preterm labor, sonographic measurement of cervical length helps distinguish between true and false labor.
-
Another study has shown an increase in mortality associated with the use of an oral IIb/IIIa receptor antagonist.
-
-
-
The Partnership for Human Research Protection recently announced the approval of final standards for a new accreditation program to safeguard the interests of human subjects participating in research efforts.
-